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Abstract
Background: The continual monitoring of population health-related quality of life (HRQoL) with validated
instruments helps public health agencies assess, protect, and promote population health. This study aimed to
determine norms for the French adolescent and adult general population for the Duke Health Profile (DUKE)
questionnaire in a large representative community sample.
Methods: We randomly selected 17,733 French people aged 12 to 75 years old in 2 steps, by households and
individuals, from the National Health Barometer 2005, a periodic population study by the French National Institute
for Prevention and Health Education. Quality of life and other data were collected by computer-assisted telephone
interview.
Results: Normative data for the French population were analyzed by age, gender and self-reported chronic
disease. Globally, function scores (best HRQoL=100) for physical, mental, social, and general health, as well as
perceived health and self-esteem, were 72.3 (SEM 0.2), 74.6 (0.2), 66.8 (0.1), 71.3 (0.1), 71.3 (0.3), 76.5 (0.1),
respectively. Dysfunction scores (worst HRQoL=100) for anxiety, depression, pain and disability domains were
30.9 (0.1), 27.6 (0.2), 34.3 (0.3), 3.1 (0.1), respectively.
Conclusion: The French norms for adolescents and adults for the DUKE could be used as a reference for other
studies assessing HRQoL, for specific illnesses, in France and for international comparisons.
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Background
Quality of life (QoL) is defined by the World Health
Organization (WHO) as ‘’the perception that an indivi-
dual has of his or her place in life, within the context of
the culture and system values in which he or she lives,
and in relation to the objectives, expectations, standards
and concerns of this individual’’ [1]. Health-related qual-
ity of life’ (HRQoL) [2,3] can be defined ‘’as an integra-
tive measure of physical and emotional well-being, level
of independence, social relationships and their relation-
ship to salient features of their environment’’ [1]. The
conceptualization of HRQoL is both objective and
subjective, so its measurement requires reference to var-
ied and complex areas, depending on the perspective.
For example, social workers will assess QoL from a dif-
ferent perspective than medical workers. HRQoL mea-
surement can also be very personal because experiences,
beliefs, and expectations and perceptions influence how
individuals think and behave [4].
HRQoL is a multidimensional concept that relates speci-
fically to a person’s health, to the measure of its function-
ing, well-being and general health perception in physical,
psychological, and social domains [2]. HRQoL measures
are used to determine the burden of disease in economic
analyses [5,6] and have become an important target in
medical care for assessing treatment outcomes in chronic
disease and an important outcome criterion in randomised
clinical trials, especially oncology [1]. In addition, HRQoL
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the physician-patient relationship, in health services
evaluation, in research and in policy making.
Many HRQOL instruments, both generic and specific
for various illnesses, have been developed to survey the
various domains of life that ill health can affect [7].
Most generic instruments are for adults, such as the
WHOQOL [8], the Sickness Impact Profile [9], the Not-
tingham Health Profile [10], the SF-36 [11], and the
Duke Health Profile (DUKE) [12-14]. However, whether
such generic instruments are suitable for young French
people is unknown. To compare the adolescent and
adult quality of life, the French Committee for Health
Promotion, in 1998, 2000 and in 2005 [15], used a ver-
sion of the DUKE suited to assess quality of life in the
12-19 age group.
The DUKE is a cross-culturally adapted, valid and useful
measure of perceived health in adolescents and adults
[12]. One of the obstacles to the success of large surveys is
the extensive time needed to complete them (by phone
conversations or self-administered). The DUKE is a
17-item short questionnaire, self-administered or inter-
viewer-administered, developed and validated in primary
care to measure patient-reported HRQoL, or functional
health status, during 1 week [13,14] and may be more
suitable than the SF-36 for older inpatients [16-18]. Its
feasibility and acceptability were reported to be good for
patients with dementia [19]. As well, another study found
the DUKE significantly better accepted than the SF-36 by
young patients [20]. Finally, the DUKE allows for briefly
exploring dimensions of self-perceived health such as
self-esteem, anxiety and depression not proposed by other
tools [21].
There is an interest in finding a simple short, self-
reporting measure of HRQoL in healthy adolescents that
is in the French language. The DUKE score has been
used primarily for research in the clinical setting, both
as a predictor of health-related outcomes and as an out-
come [22-24]. The original DUKE was developed in
English (United States) and was validated primarily in the
United States. Subsequently, the DUKE has been trans-
lated into 17 other languages and language variations
such as Afrikaans, Chinese, Dutch, Dutch (Belgium),
English (UK), French, French (Canada), German, Italian,
Korea, Norwegian, Polish, Portuguese, Spanish, Swedish,
Thai and Vietnamese. It has been translated in French
and used extensively by the Public Health School of
Nancy (France) [12,25-29].
Medical and scientific committees need validated
instruments to assess HRQoL, but general population
norms are lacking, which limits their full use in research
and clinical practice. Community norms of HRQoL are
important because they provide a base level of HRQoL
to compare illness groups or individuals’ HRQoL to
expected values. To our knowledge, norms for the
DUKE for all countries are lacking.
We aimed to use the DUKE to determine HRQoL
norms for French adolescents and adults and analyze
these by gender, age and self-reported chronic disease.
Methods
Data source
Since 1992, the French National Health Barometer, a 5-
year periodic study by the French National Institute for
Prevention and Health Education (INPES), has surveyed
behaviours, attitudes, opinions and knowledge about
health (e.g., alcohol consumption, tobacco use, drug
consumption, physical activity) and evolution of the
health of adolescents and adults in France. The whole
questionnaire includes more than 400 questions. Data
for the 2005 National Health Barometer were collected
between October 14, 2005 and February 12, 2005. This
survey was carried out in France by use of a computer-
assisted telephone interview (CATI) system with a sam-
ple of 30,514 people aged 12 to 75 years who spoke
French. Households received a letter in advance to
explain the purpose of the survey and to encourage peo-
ple in the household to take part. The eligible subject
within each household whose next birthday was nearest
the interview day was selected to answer the questions
[30]. All data collected were anonymous and self-
reported. Subjects were asked to isolate themselves
before the interview began. The mean duration of an
interview was about 40 minutes for landline phones.
Young people (younger than 15 years) had to be
accompanied by their mother or father to participate.
Parents were asked to consent to their child’s participa-
tion and that the child could be isolated to speak more
freely.
The INPES commissioned the “EA4360 Apemac”,a
French research team specialised in HRQoL studies
(School of Public Health, Nancy, France), to analyse the
data and determine norms [15].
This population-based survey was approved by the
French National Institutional Review Board (Commis-
sion Nationale Informatique et Liberté).
Sampling
Of 30,514 participants in the 2005 Health Barometer sur-
vey, 26,672 were contacted by landline phone to answer all
questions of the Health Barometer, and 3,842 persons,
without a landline phone, were contacted by their mobile
phone to answer questions related only to tobacco, alcohol
and illegal drug use because by the year 2000, more people
had only a mobile phone. When the Barometer started,
questioning all participants by mobile phone for more
than 20 minutes was difficult (problems with the battery,
attention, satellite range). So, the researchers decided to
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tobacco, alcohol, and illegal drug consumption only to
limit the duration of the interview.
Among the 26,672 participants contacted by landline
phone, 17,783 (two-thirds of the sample) were randomly
selected to participate in the QoL survey by the DUKE.
Among these, 17,733 responded to the DUKE. The
8,889 participants not randomized responded to another
HRQoL questionnaire (WHOQOL-brief) (see figure 1).
Duke Health Profile questionnaire
HRQoL was assessed by use of a French validated ver-
sion of the DUKE (Table 1), a 17-item generic self-
reporting instrument, with question responses according
to a 3-point Likert scale, which covers a 1-week time
frame [12]. The DUKE includes 10 domains. Six
domains are about health function: physical health
(items 8-12), mental health (items 1, 4, 5, 13, 14), social
health (items 2, 6, 7, 15, 16), general health (aggregation
of physical, mental and social health measures to indi-
cate overall well-being) (15 items), perceived health
(item 3) and self-esteem (items 1, 2, 4, 6, 7), with high
scores indicating better HRQoL; and 4 are about health
dysfunction: anxiety (items 2, 5, 7, 10, 12, 14), depres-
sion (items 4, 5, 10, 12, 13), pain (item 11) and disability
(item 17), with high scores indicating greater dysfunc-
tion. The DUKE is suitable for computerised telephone
administration by a trained interviewer. It can be com-
pleted in a short time and has good acceptability [14,31].
Other data collected
Like many other authors [7,32], we considered age, gen-
der and self-reported chronic disease to determine
norms.
Statistical analysis
Questionnaires were coded and calculated according to
instructions in the DUKE manual [14]. The score for
each dimension is the sum of the scores for the items,
standardized from 0 to 100. For the 6 health dimension
scores, 100 indicates the best HRQoL, whereas for the 4
dysfunction dimension scores, 100 indicates the greatest
dysfunction. Missing dimension scores were imputed if
scores were missing for < 50% of items for a dimension,
using the mean score of the items completed within
that dimension. Scores were analysed for the whole
sample and then after stratification by gender, age and
self-reported chronic disease.
Norms for the DUKE for French adolescents and
adults are presented as means, standard deviation (SD),
standard error of the mean (SEM), median (interquartile
range), minimum, maximum, and percentage of floor
and ceiling effect. In this study, with lack of consensus,
floor and ceiling effects were considered present if more
than 10% of the respondents achieved the highest or
lowest score, and strong effects if more than 30% of the
respondents achieved the highest or lowest score.
Qualitative variables were compared by Student’s
t test, with Bonferroni correction. Interaction of gender,
age groups and self-perceived chronic disease with
HRQoL was analyzed by linear regression models. Only
strong interactions are presented (p < 0.01).
Data and t test values were weighted by the number of
eligible persons in the household and by the French
population structure imputed from 1999 INSEE
(National Institute for Statistic and Economic surveys)
National Census data. In this way, the sample was repre-
sentative of the French general population between
12 and 75 years old who speak French and have a land-
line phone.
Internal consistency was assessed by Cronbach’s a,a n
inter-item correlation statistic ranging from 0-1, except
for perceived health, pain and disability domains, which
contain only one item. Higher values indicate that items
on a domain are correlated and therefore the scale mea-
sures an underlying single dimension of the question-
naire. A Cronbach a of ≥ 0.5 is usually considered
acceptable [33], but Nunnally recommends values of ≥
0.7 [34].
Statistical analysis involved use of SAS v9.1 (SAS Inc.,
Cary, NC).
Results
Description of the sample
Table 2 shows the characteristics of the observed sample
and after weighting by gender, age, geographic area and
size of community. The response rate to the HRQoL
survey was close to 100%. Among 17,783 randomly
selected people, completed questionnaires were obtained
30,514 participants in the 2005 
Health Barometer survey
3,842 participants 
contacted by their mobile
26,672 participants 
contacted by their landline
17,783 persons were 
randomly selected to 
answer the Duke 
Health Profile 
questionnaire.
8,889 people did not 
participate in the
quality-of-life survey.
17,733 persons 
answered the Duke 
questionnaire
Figure 1 Selection of the participants in the health-related
quality-of-life survey.
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Participants of the HRQoL survey (n = 17,733) and peo-
ple not randomly selected (n = 9,539) did not differ in
age, gender or self-reported chronic disease. After
weighting by the 1999 INSEE National Census data,
49.1% of the sample were males. Adolescents (12-17
years old) represented 10.5% of the sample, young adults
(18-24 years old) 11.1% and elderly people (65-75 years
old) 12%. Self-reported chronic disease prevalence was
21.7%.
Internal consistency
Internal consistency ranged from poor to good. The
Cronbach a was 0.34 for social health, 0.46 for self-
esteem, 0.57 for anxiety, 0.61 for depression, 0.62 for
physical health, 0.63 for mental health, and 0.71 for gen-
eral health. The Cronbach a for adolescents was lower
than or equal to that for adults for dimensions.
Description of norms by gender, age and self-reported
chronic disease
The HRQoL norms globally, by gender and by age are
in Table 3. In summary, mean function scores for physi-
cal, mental, social, and general health, as well as per-
ceived health and self-esteem, were 72.3 (SEM 0.2), 74.6
(0.2), 66.8 (0.1), 71.3 (0.1), 71.3 (0.3), 76.5 (0.1), respec-
tively. Dysfunction scores for anxiety, depression, pain
and disability were 30.9 (0.1), 27.6 (0.2), 34.3 (0.3), 3.1
(0.1), respectively. Scores for men were always higher
than those for women, except for social health and dis-
ability dimensions.
Mean disability, depression, self-esteem and mental
health scores were low for men (2.8 ± 15.6, 21.4 ± 19.5,
78.8 ± 18.4, 78.6 ± 19.6, respectively), and disability,
mental health, self-esteem and physical health scores
were low for women (3.5 ± 14.9, 74.6 ± 20.2, 74.4 ±
17.2, 72.3 ± 20.3, respectively). The most affected
dimension was social health for men (64.4 ± 19.2) and
pain for women (38.31 ± 33.4).
Tables 4 and 5 provide the HRQoL norms by gender,
age and self-reported chronic disease. Self-reported
chronic disease was associated with a mean decrease of
12.5 points in the score for physical health, 4.6 for men-
tal health, 2.3 for social health, 6.5 for general health,
19.3 for perceived health, and 3.2 for self-esteem and a
mean increase of 4.8 points in the score for anxiety, 5.1
for depression, 18.4 for pain and 2.5 for disability (for
the last 4 dimensions, the interpretation of the score is
inversed). All differences were statistically significant (p
< 0.001), whatever the gender and age. After adjustment
for gender and age, significant interactions were found
between self-reported chronic disease and age for per-
ceived health (p < 0.0001) and depression (p < 0.0001):
Table 1 Content of the Duke Health Profile questionnaire
Item (French version) Dimension *
1. I like who I am
(Je me trouve bien comme je suis)
Mental health, self-
esteem, anxiety
2. I am not an easy person to get along
with
(Je ne suis pas quelqu’un de facile à vivre)
Social health
3. I am basically a healthy person
(Au fond, je suis bien portant)
Perceived health
4. I give up too easily
(Je me décourage trop facilement)
Mental health, self-
esteem, depression
5. I have difficulty concentrating
(J’ai du mal à me concentrer)
Mental health, anxiety,
depression
6. I am happy with my family relationships
(Je suis content de ma vie de famille)
Social health, self-
esteem
7. I am comfortable being around people
(Je suis à l’aise avec les autres)
Social health, anxiety
8. Would you have any physical trouble or
difficulty : Walking up a flight of stairs
(Vous auriez du mal à monter un étage)
Physical health
9. Would you have any physical trouble or
difficulty : Running the length of a
football field
(Vous auriez du mal à courir une centaine de
mètres)
Physical health
10.How much trouble have you had with:
sleeping.
(Vous avez eu des problèmes de sommeil)
Physical health, anxiety,
depression
11. How much trouble have you had with:
hurting or aching in any part of your
body
(Vous avez eu des douleurs quelque part)
Physical health, pain
12. How much trouble have you had with:
getting tired easily
(Vous avez eu l’impression d’être vite fatigué(e))
Physical health, anxiety,
depression
13. How much trouble have you had with:
feeling depressed or sad
(Vous avez été triste ou déprimé(e))
Mental health,
depression
14. How much trouble have you had with:
nervousness
(Vous avez été tendu(e) ou nerveux(se))
Mental health, anxiety
15. How often did you: socialize with other
people (talk or visit with friends or
relatives).
Vous vous êtes retrouvé(e) avec les gens de
votre famille qui n’habitent pas chez vous, ou
avec des copains en dehors de l’école (posée
aux 12-17 ans) Vous avez rencontré des
parents ou des amis au cours de
conversations ou de visites (posée aux 18 ans
et plus)
Social health
16. How often did you: take part in social,
religious, or recreation activities
(meetings, church, movies, sports, parties).
(Vous avez eu des activités de groupes ou de
loisirs)
Social health
17. How often did you: stay in your home,
a nursing home, or hospital because of
sickness, injury, or other health problem
(Vous avez dû rester chez vous ou faire un
séjour en clinique ou à l’hôpital pour raison
santé)
Disability
* The general health dimension consists of all items, except items 3 and 17.
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the group with a self-reported chronic disease. We also
observed a significant interaction between gender and
self-reported chronic disease, with greater effects for
women than men in score for physical health (-14
points and -11 points, respectively, p = 0.003), general
health (-7 points and -5.7 points, respectively, p =
0.002), and pain (+23.6 points and 15.9 points, respec-
tively, p = 0.001).
We found a floor effect for anxiety, perceived health
and depression scores (6.4, 11.3 and 12.4%, respectively)
and a strong floor effect for pain and disability scores
(44.6 and 95.4%, respectively) (Table 3). Ceiling effects
were moderate for physical health (11.3%), self-esteem
(16%) and mental health (16.2%) and strong for per-
ceived health (53.9%).
Discussion
The DUKE questionnaire has been used for many years
to describe HRQoL in different patient populations but
has not been used for a general population. This is the
first study presenting norms for the DUKE for French
adolescents and adults. These normative data will be
useful to researchers who wish to use the DUKE for
health assessment and to clinical practitioners in daily
practice.
The production of HRQoL community norms is impor-
tant because they provide expected reference values to
evaluate groups or individuals’ HRQoL. Norms allow for
appreciating the impact of diseases on HRQoL by compar-
ing patients’ HRQoL with normative data. However, some
authors have suggested that norm-based interpretation in
this situation may be irrelevant [35,36] because the impact
of the disease could be underestimated. This situation
would be the case mainly in longitudinal studies if patients
changed their way of estimating HRQoL over time
because of their experience with disease or treatment, the
response-shift phenomenon. Humans actively construct
meaning from their environment and display a range of
cognitive mechanisms to continually adapt to changing
circumstances. Response shift refers to a change in the
meaning of one’s evaluation of a construct as a result of a
change in one’s internal standards of measurement, values
or construct definition. Therefore, people might give dif-
ferent answers on patient-reported outcome measures
over time, because their HRQoL has changed and because
they might have changed their perception on what health
or HRQoL means to them [37,38]. However, comparing
values between patients and the general population can be
problematic with scales that have been developed in a hos-
pital setting, but is not the case for the DUKE.
In public health, the continual monitoring of popula-
tion HRQoL with validated instruments gives public
health agencies data on current health for assessing,
protecting, and promoting population health. Tracking
population HRQoL over time also helps identify health
disparities, evaluate progress on achieving broad health
goals, and inform healthy public policy makers. These
applications complement those of clinical research and
practice, where HRQOL assessment measures patient-
reported outcomes from medical, surgical, and beha-
vioural interventions. In epidemiological research, these
measures are particularly relevant to the field of chronic
disease epidemiology by providing direct evidence of the
considerable population burden of long-term health
conditions such as disability, arthritis, obesity, asthma or
diabetes. As previously mentioned, clinicians and
researchers should carefully define their research ques-
tions related to patient-reported outcomes before select-
ing the instrument to use, by structure and content
Table 2 Characteristics of the sample
Men Women Total
n
observed
%
corrected*
n 1999 NCD n
observed
%
corrected*
n 1999 NCD n
observed
%
corrected*
n 1999 NCD
7425 49,1 22 828 184 10308 50,9 23501064 17733 - 46329248
Age, years
12-17 670 11,5 2,360,572 737 9,6 2256154 1407 10,5 4616726
18-24 638 11,9 2706126 810 10,4 2628525 1448 11,1 5334651
25-34 1400 17,8 4201394 1927 18,9 4215311 3327 18,4 8416705
35-44 1404 17,6 4246510 1919 19,6 4337674 3323 18,6 8584184
45-54 1320 18,1 4081008 1776 17,5 4110160 3096 17,8 8191168
55-64 1125 11,2 2684944 1730 12 2798797 2855 11,6 5483741
65-75 868 11,9 2284992 1409 12,2 2859393 2277 12,1 5144385
Chronic
disease
Yes 1619 20,6 4702606 2534 22,8 5358243 4153 21,7 10053447
No 5798 79,4 18125578 7761 77,2 18142821 13559 78,3 36275801
*weighted by number of eligible persons in the household and imputed from 1999 INSEE National Census Data (1999 NCD).
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Page 5 of 16Table 3 HRQoL norms* in French general population from 12 to 75 years old (n = 17,733)
Men Women Total
12-
17
18-
24
25-
34
35-
44
45-
54
55-
64
65-
75
Total 12-
17
18-
24
25-
34
35-
44
45-
54
55-
64
65-
75
Total
Physical health
n= 670 637 1396 1403 1316 1121 863 7406 733 809 1927 1910 1770 1721 1381 10251 17657
Mean 80.7 79.3 79.0 77.6 74.0 75.9 71.1 76.8 72.9 71.3 70.1 69.2 66.1 64.8 61.3 67.9 72.3
Standard deviation 19.1 20.1 17.6 18.1 22.2 18.2 23.1 19.9 20.2 20.6 18.9 20.0 20.1 18.0 19.5 19.7 20.3
Error standard of the
mean
0.6 0.6 0.4 0.5 0.6 0.6 0.7 0.2 0.7 0.7 0.5 0.5 0.5 0.5 0.6 0.2 0.2
Percentile 25 th 70.0 70.0 70.0 70.0 60.0 70.0 60.0 70.0 60.0 60.0 60.0 60.0 50.0 50.0 50.0 60.0 60.0
Median 80.0 80.0 80.0 80.0 80.0 80.0 70.0 80.0 70.0 70.0 70.0 70.0 70.0 70.0 60.0 70.0 80.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 80.0 80.0 80.0 80.0 80.0 80.0 90.0
Minimum 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.3 0.1 0.2 0.8 0.3 1.0 0.4 0.3 0.2 0.4 0.7 0.8 0.8 1.1 0.6 0.5
Ceiling effect (%) 18.0 15.6 17.1 14.4 12.8 17.0 10.1 14.9 11.2 8.4 8.7 7.7 7.0 8.1 3.9 7.8 11.3
Mental health
n= 668 637 1398 1401 1311 1123 856 7394 734 809 1924 1909 1766 1718 1387 10247 17641
Mean 74.3 75.2 80.0 79.5 78.2 81.5 81.0 78.6 65.8 67.5 72.0 71.2 70.2 72.3 74.1 70.7 74.6
Standard deviation 22.7 24.6 18.4 18.3 19.6 16.6 18.6 19.6 23.5 22.1 19.3 20.4 20.1 17.1 18.8 19.9 20.2
Error standard of the
mean
0.7 0.8 0.5 0.5 0.5 0.5 0.6 0.2 0.8 0.7 0.5 0.5 0.5 0.5 0.6 0.2 0.2
Percentile 25 th 60.0 60.0 70.0 70.0 70.0 70.0 70.0 70.0 50.0 50.0 60.0 60.0 60.0 60.0 60.0 60.0 60.0
Median 80.0 80.0 80.0 80.0 80.0 90.0 80.0 80.0 70.0 70.0 80.0 70.0 70.0 80.0 80.0 70.0 80.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 100.0 100.0 90.0 80.0 80.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0
Minimum 0.0 0.0 0.0 0.0 10.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.1 0.1 0.2 0.0 -0.0 0.1 0.0 0.1 0.4 0.2 0.4 0.1 0.8 0.5 0.5 0.4 0.2
Ceiling effect (%) 12.2 15.4 21.6 20.5 19.7 27.4 25.2 20.3 8.6 7.6 11.0 12.4 13.0 15.3 15.8 12.1 16.2
Social health
n= 669 634 1388 1387 1296 1118 841 7333 730 807 1923 1901 1756 1699 1378 10194 17527
Mean 70.3 68.1 68.7 66.4 65.7 64.9 64.4 66.9 65.7 66.7 68.6 67.0 65.5 66.7 65.7 66.7 66.8
Standard deviation 20.2 22.8 18.2 18.1 18.9 16.7 19.2 18.9 18.6 19.5 15.9 17.1 16.7 14.6 15.9 16.6 17.6
Error standard of the
mean
0.6 0.7 0.5 0.5 0.5 0.5 0.6 0.2 0.6 0.6 0.4 0.4 0.4 0.4 0.5 0.2 0.1
Percentile 25 th 60.0 60.0 60.0 60.0 50.0 50.0 50.0 60.0 50.0 60.0 60.0 60.0 50.0 50.0 50.0 60.0 60.0
Median 70.0 70.0 70.0 70.0 70.0 70.0 60.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0
Percentile 75th 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0
Minimum 20.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 10.0 0.0 0.0 10.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1
Ceiling effect (%) 6.0 5.1 4.7 3.5 3.8 3.5 4.0 4.3 2.8 4.7 4.7 5.4 4.6 6.1 5.2 4.9 4.6
General health
n= 667 633 1384 1383 1285 1113 824 7289 725 805 1921 1883 1742 1682 1336 10094 17383
Mean 75.1 74.2 75.9 74.5 72.7 74.0 72.1 74.1 68.2 68.6 70.2 69.1 67.3 67.9 67.1 68.5 71.3
Standard deviation 14.4 16.4 13.3 13.7 14.7 12.5 14.8 14.1 15.2 15.3 13.3 14.7 14.4 12.4 13.6 14.0 14.3
Error standard of the
mean
0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.2 0.5 0.5 0.3 0.4 0.4 0.4 0.4 0.1 0.1
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Page 6 of 16Table 3 HRQoL norms* in French general population from 12 to 75 years old (n = 17,733) (Continued)
Percentile 25 th 70.0 66.7 70.0 66.7 63.3 66.7 63.3 66.7 60.0 60.0 60.0 60.0 56.7 56.7 56.7 60.0 63.3
Median 76.7 76.7 76.7 76.7 73.3 76.7 73.3 76.7 70.0 70.0 73.3 70.0 66.7 70.0 70.0 70.0 73.3
Percentile 75th 83.3 83.3 83.3 83.3 83.3 83.3 83.3 83.3 80.0 80.0 80.0 80.0 76.7 80.0 76.7 80.0 80.0
Minimum 26.7 23.3 20.0 16.7 13.3 16.7 26.7 13.3 20.0 20.0 16.7 10.0 6.7 0.0 10.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 96.7 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 -0.0 0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Ceiling effect (%) 0.7 0.5 0.7 0.6 0.4 0.8 0.5 0.6 0.0 0.4 0.5 0.2 0.4 0.5 0.3 0.4 0.5
Perceived health
n= 669 638 1399 1403 1317 1121 864 7411 735 810 1925 1919 1770 1728 1403 10290 17701
Mean 71.4 75.4 78.6 76.0 69.9 67.1 64.5 72.4 69.4 72.1 74.8 73.2 69.6 67.0 61.5 70.2 71.3
Standard deviation 43.5 44.5 33.5 34.0 37.0 31.5 37.5 36.8 39.3 38.9 32.4 32.4 31.3 27.1 29.5 32.3 34.3
Error standard of the
mean
1.4 1.4 0.9 0.9 0.9 1.0 1.2 0.4 1.3 1.3 0.8 0.8 0.8 0.8 0.9 0.3 0.3
Percentile 25 th 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Median 100.0 100.0 100.0 100.0 100.0 50.0 50.0 100.0 100.0 100.0 100.0 100.0 50.0 50.0 50.0 100.0 100.0
Percentile 75th 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 13.1 11.9 8.0 8.7 11.1 11.7 13.2 10.8 14.5 13.8 11.3 10.4 10.2 12.3 13.5 11.9 11.3
Ceiling effect (%) 55.9 62.8 65.3 60.7 50.9 45.8 42.3 55.6 53.2 58.1 60.9 56.7 49.4 46.3 36.5 52.3 53.9
Self-esteem
n= 669 635 1389 1387 1295 1120 838 7333 728 807 1924 1897 1754 1697 1372 10179 17512
Mean 77.1 76.2 80.2 79.4 79.3 78.7 79.3 78.8 68.2 70.6 75.7 75.2 74.8 75.6 77.2 74.4 76.5
Standard deviation 20.6 23.7 17.7 17.8 18.0 15.8 17.7 18.4 20.0 19.7 16.4 17.4 17.6 14.6 16.2 17.2 17.9
Error standard of the
mean
0.7 0.7 0.5 0.5 0.5 0.5 0.6 0.2 0.7 0.6 0.4 0.4 0.4 0.5 0.5 0.2 0.1
Percentile 25 th 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 60.0 60.0 60.0 60.0 60.0 60.0 70.0 60.0 70.0
Median 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 70.0 70.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 80.0 80.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0
Minimum 20.0 10.0 0.0 0.0 10.0 0.0 10.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 10.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1
Ceiling effect (%) 15.2 16.0 20.6 20.0 19.4 19.2 20.5 18.9 5.6 7.0 13.6 14.3 14.2 15.7 18.2 13.2 16.0
Anxiety
n= 669 636 1394 1395 1300 1116 845 7355 731 808 1924 1898 1756 1703 1381 10201 17556
Mean 29.2 32.1 28.3 28.3 28.5 24.4 24.5 28.0 35.9 37.4 34.1 33.5 34.1 31.6 30.0 33.7 30.9
Standard deviation 22.5 23.1 18.9 18.8 19.6 16.2 17.5 19.4 21.0 20.0 16.9 18.2 17.7 15.3 16.5 17.7 18.6
Error standard of the
mean
0.7 0.7 0.5 0.5 0.5 0.5 0.6 0.2 0.7 0.7 0.4 0.4 0.4 0.5 0.5 0.2 0.1
Percentile 25 th 16.7 16.7 16.7 16.7 16.7 8.3 16.7 16.7 25.0 25.0 25.0 16.7 16.7 16.7 16.7 16.7 16.7
Median 25.0 33.3 25.0 25.0 25.0 25.0 25.0 25.0 33.3 33.3 33.3 33.3 33.3 33.3 25.0 33.3 33.3
Percentile 75th 41.7 41.7 41.7 41.7 41.7 33.3 33.3 41.7 50.0 50.0 50.0 41.7 50.0 41.7 41.7 50.0 41.7
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 83.3 91.7 100.0 91.7 91.7 91.7 83.3 100.0 91.7 91.7 91.7 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 5.6 4.3 8.0 8.0 7.5 12.7 10.5 8.0 4.4 1.5 4.0 4.1 5.2 7.8 7.4 4.9 6.4
Ceiling effect (%) 0.0 0.0 0.1 0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.1
Depression
n= 670 637 1398 1403 1313 1121 856 7398 736 810 1926 1915 1767 1721 1398 10273 17671
Mean 28.6 29.1 22.2 22.0 23.1 19.5 21.4 23.5 36.3 34.3 30.6 30.6 31.7 30.2 29.5 31.5 27.6
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Page 7 of 16criteria and perhaps according to the availability of nor-
mative data.
Methodological considerations
We found relatively low internal consistency and a strong
floor effect with the DUKE. Similar limitations were
reported in young people [39] and in dementia [16], and
in the French validity study of a cohort of 963 people from
the general population, in which the Cronbach a varied
from 0.63 to 0.81 [12]. However, this limitation should be
moderately weighed because the use of the Cronbach a to
assess the psychometric qualities of a HRQoL question-
naire might be inappropriate when the construct validity
generates dimensions with few items. The Cronbach a is
sensitive to the number of items in the dimension; with
increasing number of items, the Cronbach a is likely to
increase. In addition, the lower the mean inter-item corre-
lation, the lower the Cronbach a.
We also showed some moderate and high floor effects
in dysfunction measures (anxiety, depression, pain and
disability) of the DUKE, which indicates poor discrimi-
nation properties. This finding was not surprising in a
sample from a general population, which is, on average,
in good health. These dimension scores are probably
sensitive to the impact of disease, as we observed in
other studies in patient samples [21,40].
Table 3 HRQoL norms* in French general population from 12 to 75 years old (n = 17,733) (Continued)
Standard deviation 24.2 24.6 19.1 18.3 20.3 16.8 19.5 20.2 23.6 22.3 19.4 20.2 20.0 17.1 18.9 19.9 20.4
Error standard of the
mean
0.8 0.8 0.5 0.5 0.5 0.5 0.6 0.2 0.8 0.7 0.5 0.5 0.5 0.5 0.6 0.2 0.2
Percentile 25 th 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 20.0 20.0 20.0 20.0 20.0 10.0 10.0 20.0 10.0
Median 30.0 30.0 20.0 20.0 20.0 20.0 20.0 20.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0 20.0
Percentile 75th 40.0 40.0 30.0 30.0 30.0 30.0 30.0 30.0 50.0 50.0 40.0 40.0 40.0 40.0 40.0 40.0 40.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 90.0 100.0 100.0 100.0 100.0 80.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 9.3 8.7 15.9 15.8 17.4 23.8 18.6 15.7 7.3 5.9 8.5 9.2 9.1 11.9 11.2 9.1 12.4
Ceiling effect (%) 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.6 0.3 0.5 0.1 0.7 0.3 0.7 0.4 0.3
Pain
n= 670 638 1398 1404 1320 1124 867 7421 736 810 1927 1919 1775 1729 1406 10302 17723
Mean 22.6 25.7 26.3 29.3 35.3 33.2 39.0 30.2 29.4 32.4 33.8 36.2 41.8 45.3 47.9 38.2 34.3
Standard deviation 37.4 41.5 32.8 33.3 37.3 30.5 36.9 35.6 34.0 37.7 32.8 33.4 33.8 28.9 32.3 33.4 34.5
Error standard of the
mean
1.2 1.3 0.8 0.9 0.9 1.0 1.1 0.4 1.2 1.2 0.8 0.8 0.9 0.9 1.0 0.4 0.3
Percentile 25 th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Median 0.0 0.0 0.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Percentile 75th 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 61.1 57.4 54.5 49.7 42.5 43.9 36.3 49.2 48.9 48.4 45.9 42.0 35.4 31.9 28.8 40.1 44.6
Ceiling effect (%) 6.4 8.7 7.0 8.2 13.0 10.3 14.3 9.7 7.6 13.2 13.5 14.3 18.9 22.5 24.6 16.4 13.1
Disability
n= 670 638 1399 1403 1319 1125 867 7421 737 810 1926 1919 1775 1730 1407 10304 17725
Mean 2.7 2.3 2.4 3.3 2.7 2.2 3.9 2.8 2.7 3.2 4.6 3.6 3.5 3.1 2.7 3.5 3.1
Standard deviation 15.6 15.9 13.8 16.4 15.8 12.2 19.5 15.6 14.2 14.4 17.0 16.0 15.8 12.3 12.5 14.9 15.2
Error standard of the
mean
0.5 0.5 0.4 0.4 0.4 0.4 0.6 0.2 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.2 0.1
Percentile 25 th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Median 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Percentile 75th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 95.4 96.3 96.5 95.1 96.3 96.9 95.1 96.0 95.5 94.2 93.3 94.9 95.3 95.7 96.2 94.9 95.4
Ceiling effect (%) 0.7 0.9 1.2 1.8 1.7 1.3 2.8 1.5 0.9 0.6 2.4 2.2 2.4 1.9 1.5 1.9 1.7
*Weighted by number of eligible persons in the household and imputed from 1999 INSEE National Census data.
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Page 8 of 16Table 4 HRQoL norms* in French general population from 12 to 75 years old with self-reported chronic disease
(n = 4,153)
Men Women Total
12-
17
18-
24
25-
34
35-
44
45-
54
55-
64
65-
75
Total 12-
17
18-
24
25-
34
35-
44
45-
54
55-
64
65-
75
Total
Physical health
n= 62 44 177 222 329 375 402 1611 55 105 276 338 489 631 625 2519 4130
Mean 74.2 72.1 69.2 70.1 66.5 68.3 65.7 68.0 60.0 61.9 63.4 57.2 55.9 57.3 55.4 57.6 62.5
Standard deviation 23.7 20.8 21.4 20.2 25.2 19.6 23.7 22.4 21.8 21.7 20.1 23.5 20.4 18.2 19.6 20.3 21.7
Error standard of the
mean
2.5 2.4 1.6 1.3 1.3 1.1 1.1 0.5 2.7 2.0 1.3 1.3 1.0 0.9 0.9 0.4 0.4
Percentile 25 th 60.0 60.0 60.0 60.0 50.0 60.0 50.0 60.0 50.0 50.0 50.0 40.0 40.0 40.0 40.0 40.0 50.0
Median 80.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 60.0 60.0 70.0 60.0 60.0 60.0 60.0 60.0 70.0
Percentile 75th 90.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 70.0 80.0 80.0 80.0 70.0 70.0 70.0 70.0 80.0
Minimum 20.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 10.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.5 0.8 1.4 0.6 1.6 1.0 0.0 0.0 0.0 2.5 1.8 1.1 1.8 1.4 1.2
Ceiling effect (%) 16.2 7.7 9.1 3.3 6.7 9.2 4.5 6.9 4.2 3.7 4.4 2.4 2.5 3.4 1.2 2.7 4.6
Mental health
n= 62 44 178 221 329 376 401 1611 55 105 276 338 486 628 620 2508 4119
Mean 67.9 73.8 74.4 73.4 74.6 78.2 79.1 75.9 61.8 65.7 67.4 65.0 63.2 68.3 70.4 66.8 71.0
Standard deviation 26.5 23.3 21.4 19.6 20.6 17.2 18.2 19.8 24.0 24.6 21.0 23.1 21.3 17.4 19.3 20.5 20.7
Error standard of the
mean
2.8 2.7 1.6 1.3 1.1 0.9 0.8 0.5 3.0 2.2 1.4 1.3 1.0 0.9 0.9 0.5 0.3
Percentile 25 th 50.0 60.0 60.0 60.0 60.0 70.0 70.0 60.0 50.0 50.0 50.0 50.0 50.0 60.0 60.0 50.0 60.0
Median 70.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 60.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 80.0 80.0 80.0 80.0 80.0 90.0 90.0 80.0 90.0
Minimum 20.0 20.0 0.0 0.0 10.0 0.0 10.0 0.0 10.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 1.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 1.5 0.1 1.6 0.7 1.0 0.9 0.6
Ceiling effect (%) 9.1 8.7 13.1 12.3 14.9 21.2 17.7 15.7 6.0 7.4 7.0 8.2 7.8 8.4 10.9 8.5 11.9
Social health
n= 62 45 176 217 327 374 392 1593 55 105 276 336 486 623 617 2498 4091
Mean 67.9 69.6 69.0 65.4 64.3 64.5 63.1 65.1 66.2 64.8 68.9 63.7 63.9 65.8 64.0 65.0 65.0
Standard deviation 22.0 23.8 19.4 19.7 19.4 17.1 19.9 19.4 19.6 22.6 15.9 18.8 17.4 15.2 16.6 17.1 18.0
Error standard of the
mean
2.3 2.8 1.4 1.3 1.0 0.9 0.9 0.5 2.4 2.0 1.0 1.0 0.9 0.8 0.8 0.4 0.3
Percentile 25 th 60.0 60.0 60.0 50.0 50.0 50.0 50.0 50.0 60.0 50.0 60.0 50.0 50.0 50.0 50.0 50.0 50.0
Median 70.0 70.0 70.0 60.0 60.0 70.0 60.0 70.0 70.0 70.0 70.0 60.0 70.0 70.0 70.0 70.0 70.0
Percentile 75th 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0
Minimum 20.0 10.0 0.0 10.0 0.0 0.0 10.0 0.0 0.0 10.0 20.0 10.0 0.0 0.0 10.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 90.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.4 0.0 0.5 0.4 0.0 0.2 2.5 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.2
Ceiling effect (%) 8.9 11.7 6.9 5.4 4.8 2.1 4.3 5.0 0.0 8.4 4.9 4.2 4.9 5.9 5.2 5.1 5.0
General health
n= 62 44 175 216 324 374 385 1580 55 105 276 333 481 614 599 2463 4043
Mean 70.0 71.9 71.0 69.7 68.4 70.3 69.2 69.6 62.7 64.2 66.6 62.0 61.0 63.8 63.3 63.1 66.2
Standard deviation 17.7 14.5 15.3 15.0 16.0 13.0 14.5 14.8 15.7 16.5 14.0 17.3 15.1 12.6 13.6 14.5 14.9
Error standard of the
mean
1.9 1.7 1.1 1.0 0.8 0.7 0.7 0.4 1.9 1.5 0.9 1.0 0.7 0.6 0.6 0.3 0.2
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Page 9 of 16Table 4 HRQoL norms* in French general population from 12 to 75 years old with self-reported chronic disease
(n = 4,153) (Continued)
Percentile 25 th 60.0 66.7 63.3 60.0 56.7 63.3 60.0 60.0 53.3 53.3 56.7 50.0 50.0 53.3 53.3 53.3 56.7
Median 70.0 73.3 73.3 73.3 70.0 73.3 70.0 73.3 63.3 66.7 70.0 63.3 63.3 66.7 63.3 63.3 66.7
Percentile 75th 80.0 80.0 83.3 80.0 80.0 80.0 80.0 80.0 73.3 76.7 76.7 73.3 73.3 76.7 73.3 73.3 76.7
Minimum 36.7 26.7 20.0 30.0 13.3 16.7 26.7 13.3 26.7 23.3 16.7 10.0 6.7 16.7 10.0 6.7 6.7
Maximum 93.3 86.7 96.7 100.0 96.7 100.0 96.7 100.0 86.7 93.3 96.7 96.7 100.0 96.7 96.7 100.0 100.0
Floor effect (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ceiling effect (%) 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1
Perceived health
n= 62 45 178 222 330 374 403 1614 55 105 275 340 489 633 631 2528 4142
Mean 70.8 80.5 66.6 59.9 53.9 51.5 52.0 57.0 66.9 60.6 62.7 57.6 54.0 53.3 50.3 55.4 56.2
Standard deviation 40.1 34.4 34.0 39.9 38.7 32.7 36.5 37.2 39.2 43.2 34.3 35.8 33.0 27.4 28.3 32.0 34.1
Error standard of the
mean
4.3 4.0 2.5 2.5 2.0 1.8 1.7 0.9 4.8 3.9 2.2 2.0 1.6 1.4 1.3 0.7 0.6
Percentile 25 th 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Median 100.0 100.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Percentile 75th 100.0 100.0 100.0 100.0 100.0 100.0 50.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 50.0 100.0 100.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 10.1 2.0 11.0 20.5 22.7 22.8 20.2 19.0 13.9 23.4 17.5 20.1 21.9 20.9 20.8 20.5 19.8
Ceiling effect (%) 51.6 63.0 44.2 40.4 30.4 25.8 24.3 33.1 47.6 44.5 42.8 35.4 30.0 27.6 21.4 31.3 32.2
Self-esteem
n= 62 45 176 217 327 375 391 1593 55 105 276 335 483 619 612 2485 4078
Mean 71.7 77.5 77.8 74.5 77.4 76.2 77.5 76.6 66.8 68.6 73.1 70.5 70.3 72.7 73.8 71.7 74.0
Standard deviation 20.7 21.4 18.5 19.1 19.5 16.8 17.9 18.5 20.4 22.3 16.4 19.4 19.0 14.9 16.4 17.4 18.0
Error standard of the
mean
2.2 2.5 1.4 1.2 1.0 0.9 0.8 0.4 2.5 2.0 1.1 1.1 0.9 0.8 0.8 0.4 0.3
Percentile 25 th 60.0 70.0 70.0 60.0 70.0 70.0 70.0 70.0 60.0 60.0 60.0 60.0 60.0 60.0 60.0 60.0 60.0
Median 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 70.0 70.0 80.0 70.0 70.0 80.0 80.0 70.0 80.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 80.0 90.0 90.0 80.0 90.0 90.0 90.0 90.0 90.0
Minimum 40.0 10.0 20.0 0.0 10.0 0.0 10.0 0.0 10.0 10.0 20.0 0.0 0.0 0.0 20.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.2 0.1
Ceiling effect (%) 6.4 12.4 17.2 14.2 17.8 14.7 15.0 15.1 2.9 10.5 10.6 7.1 10.4 11.2 13.0 10.4 12.6
Anxiety
n= 62 44 177 220 328 375 395 1601 55 105 276 336 486 626 620 2504 4105
Mean 36.2 35.7 35.0 34.5 32.1 28.2 26.5 30.9 43.5 41.8 38.8 41.8 40.5 35.8 33.2 38.1 34.7
Standard deviation 25.3 22.7 19.9 20.5 20.2 17.3 17.1 19.4 21.5 20.7 17.4 19.8 17.4 15.5 16.9 17.7 18.7
Error standard of the
mean
2.7 2.6 1.5 1.3 1.0 1.0 0.8 0.5 2.6 1.9 1.1 1.1 0.9 0.8 0.8 0.4 0.3
Percentile 25 th 25.0 25.0 25.0 16.7 16.7 16.7 16.7 16.7 33.3 25.0 25.0 25.0 25.0 25.0 16.7 25.0 16.7
Median 33.3 41.7 33.3 33.3 33.3 25.0 25.0 25.0 41.7 41.7 41.7 41.7 41.7 33.3 33.3 33.3 33.3
Percentile 75th 50.0 41.7 50.0 50.0 41.7 41.7 33.3 41.7 50.0 58.3 50.0 50.0 50.0 50.0 41.7 50.0 50.0
Minimum 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 83.3 75.0 100.0 91.7 91.7 91.7 83.3 100.0 91.7 91.7 91.7 100.0 100.0 91.7 91.7 100.0 100.0
Floor effect (%) 3.3 0.0 3.1 3.9 5.6 7.1 6.7 5.3 4.4 0.0 1.2 0.6 2.0 4.9 6.2 3.2 4.2
Ceiling effect (%) 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.2 0.2
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Page 10 of 16The response rate of the 2005 Health Barometer tele-
phone survey was about 64% (30,514 participants in the
2005 Health Barometer of almost 48,000 contacted),
which is lower than the response rate of mail surveys.
To be representative of French population, data col-
lected from 2005 Health Barometer have been weighted
by number of eligible persons in the household (and by
the number of landline phones in the household) and
imputed from 1999 INSEE National Census data on
gender, age, geographic area and size of agglomeration.
In this way, the sample used for this study was represen-
tative of these criteria of the French population aged 12
to 75 years old, who speak French and have a landline
phone. Characteristics of subjects selected (n = 17,733)
and not selected (n = 8,889) for the HRQoL survey
group were similar, but despite these precautions and
checks, we cannot totally exclude the existence of selec-
tion bias.
Table 4 HRQoL norms* in French general population from 12 to 75 years old with self-reported chronic disease
(n = 4,153) (Continued)
Depression
n= 62 44 178 222 330 376 400 1612 55 105 276 339 487 631 627 2520 4132
Mean 35.7 33.3 28.7 27.1 27.7 23.6 23.1 26.3 44.9 37.1 35.5 38.7 39.1 34.0 32.9 36.2 31.6
Standard deviation 30.5 26.5 21.3 19.4 22.0 17.9 19.4 20.9 26.2 24.2 21.0 22.2 20.2 17.2 19.4 20.2 21.0
Error standard of the
mean
3.2 3.1 1.6 1.2 1.1 1.0 0.9 0.5 3.2 2.2 1.4 1.2 1.0 0.9 0.9 0.4 0.3
Percentile 25 th 20.0 20.0 10.0 10.0 10.0 10.0 10.0 10.0 30.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0
Median 30.0 30.0 30.0 30.0 20.0 20.0 20.0 20.0 50.0 30.0 30.0 40.0 40.0 30.0 30.0 30.0 30.0
Percentile 75th 50.0 50.0 40.0 40.0 40.0 40.0 30.0 40.0 60.0 50.0 50.0 60.0 50.0 50.0 50.0 50.0 50.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 80.0 100.0 100.0 100.0 90.0 80.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 7.7 6.4 9.6 8.4 13.3 16.4 13.9 12.4 4.4 5.6 5.0 3.7 2.8 7.1 8.9 5.7 8.8
Ceiling effect (%) 3.4 0.0 0.4 0.5 0.2 0.0 0.0 0.3 1.5 1.7 2.1 0.3 1.6 0.3 1.4 1.2 0.8
Pain
n= 62 45 177 222 331 375 404 1616 55 105 276 340 490 635 632 2533 4149
Mean 34.5 39.9 41.0 41.2 44.9 43.0 44.6 42.8 41.2 53.7 46.5 52.3 56.1 55.9 56.8 53.9 48.7
Standard deviation 39.2 46.8 37.7 34.2 39.5 32.4 38.1 36.9 36.5 39.6 34.8 36.9 34.8 29.2 32.3 33.6 35.3
Error standard of the
mean
4.2 5.4 2.8 2.2 2.0 1.8 1.7 0.9 4.5 3.6 2.2 2.0 1.7 1.5 1.5 0.7 0.6
Percentile 25 th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 50.0 50.0 50.0 50.0 0.0
Median 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Percentile 75th 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 100.0 50.0 100.0 100.0 100.0 100.0 100.0 100.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 41.6 38.1 37.8 31.3 32.9 31.8 30.2 32.9 32.1 23.2 31.5 26.0 23.1 22.1 21.5 24.3 28.3
Ceiling effect (%) 10.6 17.8 19.8 13.7 22.7 17.8 19.5 18.6 14.5 30.6 24.4 30.6 35.4 34.0 35.1 32.0 25.8
Disability
n= 62 45 178 222 331 376 404 1618 55 105 276 340 490 635 633 2534 4152
Mean 5.5 2.0 6.9 6.7 4.1 3.5 5.8 5.1 3.7 5.5 6.6 6.1 5.6 4.5 3.7 5.1 5.1
Standard deviation 20.5 12.8 22.6 23.4 19.2 15.1 24.2 20.7 14.5 19.1 21.0 20.2 19.1 14.8 14.7 17.4 18.7
Error standard of the
mean
2.2 1.5 1.7 1.5 1.0 0.8 1.1 0.5 1.8 1.7 1.4 1.1 0.9 0.7 0.7 0.4 0.3
Percentile 25 th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Median 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Percentile 75th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 50.0 100.0 100.0 100.0 100.0 100.0 100.0 50.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 90.0 95.9 90.1 90.8 94.6 95.0 92.9 93.1 92.6 90.3 91.1 90.8 92.5 93.8 94.8 92.7 92.9
Ceiling effect (%) 1.0 0.0 3.9 4.1 2.7 1.9 4.6 3.2 0.0 1.3 4.3 3.1 3.6 2.8 2.2 2.9 3.0
* Weighted by number of eligible persons in the household and imputed from 1999 INSEE National Census data.
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Page 11 of 16Table 5 HRQoL norms* in French general population from 12 to 75 years old with no self-reported chronic disease
(n = 13559)
Men Women Total
12-
17
18-
24
25-
34
35-
44
45-
54
55-
64
65-
75
Total 12-
17
18-
24
25-
34
35-
44
45-
54
55-
64
65-
75
Total
Physical health
n= 608 593 1217 1180 985 745 460 5788 676 703 1648 1571 1279 1089 753 7719 13507
Mean 81.3 79.8 80.4 79.1 76.3 79.7 75.8 79.1 73.9 72.7 71.2 72.0 69.8 69.1 66.0 71.0 75.0
Standard deviation 18.4 19.8 16.5 17.2 20.5 16.3 21.3 18.4 19.6 20.0 18.4 18.2 18.8 16.9 18.4 18.6 19.0
Error standard of the
mean
0.6 0.6 0.4 0.5 0.6 0.6 0.9 0.2 0.7 0.7 0.5 0.5 0.6 0.6 0.8 0.2 0.2
Percentile 25 th 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 60.0 60.0 60.0 60.0 60.0 60.0 50.0 60.0 60.0
Median 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 70.0 70.0 80.0 70.0 70.0 70.0 70.0 80.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 80.0 80.0 80.0 80.0 90.0 90.0
Minimum 20.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.3 0.0 0.1 0.6 0.2 0.4 0.2 0.4 0.2 0.5 0.3 0.4 0.7 0.6 0.4 0.3
Ceiling effect (%) 18.1 16.2 18.2 16.5 14.7 21.0 15.1 17.0 11.7 9.1 9.4 8.9 8.6 10.9 6.0 9.2 13.1
Mental health
n= 606 593 1218 1179 981 745 454 5776 677 703 1646 1570 1278 1089 764 7727 13503
Mean 74.9 75.3 80.8 80.6 79.3 83.1 82.6 79.3 66.0 67.7 72.8 72.6 72.8 74.6 77.0 71.9 75.6
Standard deviation 22.1 24.7 17.8 17.9 19.2 16.1 18.9 19.4 23.4 21.7 18.9 19.5 19.1 16.6 17.8 19.6 19.9
Error standard of the
mean
0.7 0.8 0.5 0.5 0.6 0.6 0.8 0.2 0.8 0.8 0.5 0.5 0.6 0.6 0.7 0.2 0.2
Percentile 25 th 60.0 60.0 70.0 70.0 70.0 70.0 70.0 70.0 50.0 50.0 60.0 60.0 60.0 60.0 70.0 60.0 60.0
Median 80.0 80.0 80.0 80.0 80.0 90.0 90.0 80.0 70.0 70.0 80.0 80.0 70.0 80.0 80.0 70.0 80.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 100.0 100.0 90.0 80.0 80.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0
Minimum 0.0 0.0 20.0 10.0 20.0 10.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.1 0.5 0.4 0.2 0.3 0.2
Ceiling effect (%) 12.5 15.9 22.8 22.1 21.2 30.6 31.9 21.5 8.7 7.6 11.7 13.3 14.9 19.4 19.6 13.2 17.3
Social health
n= 607 589 1210 1169 967 742 448 5732 674 701 1644 1564 1268 1075 758 7684 13416
Mean 70.5 68.0 68.7 66.6 66.1 65.2 65.5 67.4 65.6 67.0 68.6 67.8 66.1 67.2 67.1 67.2 67.3
Standard deviation 20.0 22.7 18.1 17.8 18.7 16.6 18.5 18.8 18.5 19.0 15.9 16.6 16.4 14.2 15.3 16.4 17.5
Error standard of the
mean
0.7 0.7 0.5 0.5 0.5 0.7 0.8 0.2 0.7 0.7 0.4 0.4 0.5 0.6 0.6 0.2 0.1
Percentile 25 th 60.0 60.0 60.0 60.0 60.0 50.0 50.0 60.0 50.0 60.0 60.0 60.0 50.0 60.0 60.0 60.0 60.0
Median 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0
Percentile 75th 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0
Minimum 20.0 10.0 0.0 0.0 0.0 10.0 0.0 0.0 10.0 10.0 0.0 10.0 10.0 0.0 20.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 -0.0 0.0 0.1 0.0 0.0 0.2 -0.0 0.0 0.0
Ceiling effect (%) 5.7 4.5 4.5 3.1 3.5 4.2 3.7 4.1 3.0 4.1 4.6 5.7 4.5 6.2 5.1 4.8 4.5
General health
n= 605 589 1207 1166 960 738 438 5703 669 699 1643 1549 1259 1067 734 7620 13323
Mean 75.6 74.4 76.6 75.4 74.0 76.0 74.6 75.3 68.6 69.2 70.8 70.8 69.6 70.3 70.2 70.1 72.7
Standard deviation 13.8 16.6 12.9 13.2 13.9 11.8 14.5 13.7 15.1 15.0 13.1 13.6 13.5 11.9 12.9 13.5 13.8
Error standard of the
mean
0.5 0.5 0.3 0.4 0.4 0.5 0.6 0.2 0.5 0.5 0.3 0.4 0.4 0.5 0.5 0.2 0.1
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Page 12 of 16Table 5 HRQoL norms* in French general population from 12 to 75 years old with no self-reported chronic disease
(n = 13559) (Continued)
Percentile 25 th 70.0 66.7 70.0 66.7 66.7 66.7 66.7 66.7 60.0 60.0 63.3 63.3 60.0 60.0 63.3 60.0 63.3
Median 76.7 76.7 76.7 76.7 73.3 76.7 76.7 76.7 70.0 70.0 73.3 73.3 70.0 73.3 73.3 70.0 73.3
Percentile 75th 83.3 83.3 86.7 86.7 83.3 86.7 83.3 83.3 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 83.3
Minimum 26.7 23.3 26.7 16.7 13.3 23.3 30.0 13.3 20.0 20.0 23.3 20.0 16.7 0.0 10.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 96.7 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.0 0.0 0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Ceiling effect (%) 0.7 0.5 0.8 0.6 0.5 1.1 0.9 0.7 0.0 0.5 0.6 0.3 0.5 0.8 0.6 0.4 0.6
Perceived health
n= 607 593 1219 1180 985 745 460 5789 678 704 1647 1578 1279 1094 769 7749 13538
Mean 71.4 75.0 80.3 79.1 75.1 75.2 75.6 76.4 69.5 73.9 76.8 76.7 75.3 75.0 70.4 74.6 75.5
Standard deviation 43.8 45.1 33.1 31.8 34.6 28.1 34.2 35.4 39.3 37.9 31.7 30.6 28.8 24.8 28.1 31.3 33.1
Error standard of the
mean
1.5 1.5 0.9 0.9 1.0 1.1 1.5 0.4 1.4 1.3 0.8 0.8 0.8 0.9 1.1 0.4 0.3
Percentile 25 th 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Median 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 50.0 100.0 100.0
Percentile 75th 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 13.4 12.7 7.7 6.5 7.3 5.8 7.1 8.6 14.6 12.4 10.3 8.2 6.0 7.2 7.6 9.3 9.0
Ceiling effect (%) 56.3 62.8 68.2 64.6 57.5 56.2 58.2 61.4 53.6 60.1 63.9 61.6 56.5 57.1 48.5 58.5 60.0
Self-esteem
n= 607 590 1211 1169 966 743 446 5732 672 701 1646 1561 1269 1077 757 7683 13415
Mean 77.6 76.2 80.5 80.4 79.8 79.9 80.9 79.4 68.2 70.9 76.1 76.3 76.4 77.2 80.0 75.1 77.2
Standard deviation 20.5 23.9 17.5 17.4 17.4 15.2 17.5 18.4 20.0 19.3 16.3 16.8 16.8 14.4 15.5 17.1 17.8
Error standard of the
mean
0.7 0.8 0.5 0.5 0.5 0.6 0.8 0.2 0.7 0.7 0.4 0.4 0.5 0.6 0.6 0.2 0.2
Percentile 25 th 70.0 70.0 70.0 70.0 70.0 70.0 70.0 70.0 60.0 60.0 70.0 70.0 70.0 70.0 70.0 60.0 70.0
Median 80.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0 70.0 70.0 80.0 80.0 80.0 80.0 80.0 80.0 80.0
Percentile 75th 90.0 90.0 90.0 90.0 90.0 90.0 100.0 90.0 80.0 80.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0
Minimum 20.0 10.0 0.0 0.0 10.0 30.0 10.0 0.0 0.0 0.0 10.0 0.0 10.0 0.0 10.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 0.0 0.0 0.1 0.1 0.0 -0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0
Ceiling effect (%) 16.1 16.3 21.1 21.1 19.8 21.6 25.4 19.9 5.8 6.5 14.1 15.9 15.6 18.4 22.3 14.0 17.0
Anxiety
n= 607 592 1215 1174 971 740 449 5748 674 702 1645 1561 1268 1076 758 7684 13432
Mean 28.6 31.8 27.4 27.1 27.3 22.4 22.6 27.3 35.3 36.8 33.3 31.7 31.8 29.1 27.5 32.4 29.9
Standard deviation 22.1 23.1 18.6 18.3 19.2 15.3 17.7 19.3 20.9 19.8 16.7 17.4 17.3 14.8 15.8 17.5 18.5
Error standard of the
mean
0.7 0.7 0.5 0.5 0.6 0.6 0.8 0.2 0.7 0.7 0.4 0.5 0.5 0.6 0.6 0.2 0.2
Percentile 25 th 16.7 16.7 16.7 16.7 16.7 8.3 8.3 16.7 25.0 25.0 25.0 16.7 16.7 16.7 16.7 16.7 16.7
Median 25.0 33.3 25.0 25.0 25.0 16.7 16.7 25.0 33.3 33.3 33.3 33.3 33.3 25.0 25.0 33.3 25.0
Percentile 75th 41.7 41.7 41.7 41.7 41.7 33.3 33.3 41.7 50.0 50.0 41.7 41.7 41.7 41.7 41.7 41.7 41.7
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 83.3 91.7 91.7 91.7 91.7 83.3 75.0 91.7 91.7 83.3 91.7 91.7 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 5.8 4.6 8.7 8.8 8.1 15.7 13.9 8.7 4.4 1.8 4.4 4.9 6.4 9.4 8.3 5.4 7.0
Ceiling effect (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0
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Page 13 of 16Finally, the “next-birthday” method used in this
national survey [30] to select the person to answer the
questions can generate a low “self-selection” phenom-
enon. However, the results of the selection obtained
with this method were very close to those expected. We
could have used the Kish method, but it requires, before
the selection, describing exactly the whole family, more
time and more risk of generating refusals than does the
next-birthday method.
Conclusions
We present HRQoL norms for all dimensions of the DUKE
for adolescents and adults in France. These norms could be
used as a reference for other studies assessing HRQoL, for
specific illnesses, and for international comparisons.
List of abbreviations
HRQoL: Health-related quality of life; DUKE: DUKE health profile
questionnaire; INPES: Institut National de Prévention et d’Education pour la
Santé (French National Institute for Prevention and Health Education);
Table 5 HRQoL norms* in French general population from 12 to 75 years old with no self-reported chronic disease
(n = 13559) (Continued)
Depression
n= 608 593 1218 1180 982 744 455 5780 679 704 1647 1575 1278 1089 768 7740 13520
Mean 27.9 28.8 21.3 21.0 21.7 17.4 19.8 22.8 35.6 33.9 29.7 28.8 29.0 27.9 26.8 30.1 26.5
Standard deviation 23.3 24.5 18.6 18.0 19.4 15.9 19.6 20.0 23.2 22.0 19.0 19.3 19.3 16.8 18.1 19.6 20.1
Error standard of the
mean
0.8 0.8 0.5 0.5 0.6 0.6 0.8 0.2 0.8 0.8 0.5 0.5 0.6 0.6 0.7 0.2 0.2
Percentile 25 th 10.0 10.0 10.0 10.0 10.0 0.0 10.0 10.0 20.0 20.0 20.0 10.0 10.0 10.0 10.0 10.0 10.0
Median 20.0 30.0 20.0 20.0 20.0 10.0 20.0 20.0 30.0 30.0 30.0 30.0 30.0 30.0 20.0 30.0 20.0
Percentile 75th 40.0 40.0 30.0 30.0 30.0 30.0 30.0 30.0 50.0 50.0 40.0 40.0 40.0 40.0 40.0 40.0 40.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 90.0 90.0 90.0 90.0 90.0 100.0 70.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 9.4 8.9 16.7 17.1 18.7 27.6 22.8 16.6 7.5 6.0 9.1 10.5 11.4 14.7 13.0 10.1 13.3
Ceiling effect (%) 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.4 0.4 0.1 0.2 0.1
Pain
n= 608 593 1219 1181 987 747 462 5797 679 704 1648 1578 1283 1093 771 7756 13553
Mean 21.5 24.6 24.3 27.0 32.1 28.2 34.0 26.9 28.5 29.2 31.7 32.5 36.5 39.1 40.9 33.5 30.3
Standard deviation 36.9 40.8 31.5 32.6 36.0 28.4 35.0 34.3 33.6 36.2 32.1 31.6 32.1 27.5 30.8 32.0 33.2
Error standard of the
mean
1.2 1.3 0.9 0.9 1.0 1.1 1.5 0.4 1.2 1.3 0.8 0.8 0.9 1.1 1.2 0.4 0.3
Percentile 25 th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Median 0.0 0.0 0.0 0.0 50.0 0.0 50.0 0.0 0.0 0.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Percentile 75th 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 63.0 58.9 56.7 53.2 45.6 50.1 41.7 53.5 50.2 52.2 48.3 45.7 39.9 37.6 34.6 44.8 49.1
Ceiling effect (%) 6.0 8.0 5.3 7.1 9.9 6.4 9.7 7.4 7.1 10.6 11.6 10.6 13.0 15.8 16.4 11.8 9.6
Disability
n= 608 593 1219 1180 986 747 462 5795 680 704 1647 1578 1283 1094 771 7757 13552
Mean 2.4 2.3 1.8 2.7 2.3 1.6 2.1 2.2 2.6 2.8 4.2 3.1 2.8 2.3 1.9 3.0 2.6
Standard deviation 15.0 16.1 11.9 14.7 14.5 10.5 14.0 13.7 14.2 13.5 16.3 14.9 14.4 10.5 10.4 14.0 13.9
Error standard of the
mean
0.5 0.5 0.3 0.4 0.4 0.4 0.6 0.2 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.2 0.1
Percentile 25 th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Median 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Percentile 75th 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Maximum 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Floor effect (%) 95.9 96.4 97.3 96.0 96.8 97.9 97.0 96.7 95.7 94.9 93.7 95.9 96.3 96.8 97.2 95.6 96.1
Ceiling effect (%) 0.7 1.0 0.8 1.4 1.3 1.0 1.2 1.1 0.9 0.5 2.1 2.0 1.9 1.4 0.9 1.6 1.3
* Weighted by number of eligible persons in the household and imputed from 1999 INSEE National Census data.
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